Optimization of beta-blockers for cardiovascular care.
D000319:Adrenergic beta-Antagonists / Q000145:classification / Q000627:therapeutic use*; D001682:Biological Availability; D017298:Bisoprolol; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D011412:Propanolamines / Q000097:blood / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D017298:Bisoprolol